Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy - Poll - MDSpire

Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy

  • By

  • Sophia Kennedy

  • Jerin Thomas

  • Stella D’Arcy

  • Ivie Odia

  • Dev Kamdar

  • Lucio Pereira

  • Danielle Scarola

  • Brett Miles

  • Douglas Frank

  • Charit Taneja

  • Nagashree Seetharamu

  • Rajarsi Mandal

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy

  • by Sophia Kennedy, Jerin Thomas, Stella D’Arcy, Ivie Odia, Dev Kamdar, Lucio Pereira, Danielle Scarola, Brett Miles, Douglas Frank, Charit Taneja, Nagashree Seetharamu, Rajarsi Mandal

  • May 28, 2026

Related Content

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship